As President-elect Donald Trump fills out his administration’s leadership ranks, the life sciences ecosystem is watching closely. Trump’s nominees could significantly influence the landscape of healthcare, medical innovation, research, and public health across the U.S. and here in Colorado. Life sciences companies, researchers, and all those who are interested in public health and health innovation are eagerly awaiting clarity on how these nominees will impact regulatory frameworks, funding, and the future of health policy.
Among the individuals who have been tapped to serve in roles in the Trump Administration are Robert F. Kennedy Jr., J.D., as Secretary of Health & Human Services (HHS), Marty Makary, M.D., M.P.H., as Commissioner of the Food & Drug Administration (FDA), Mehmet Oz, M.D., M.B.A., as the Centers for Medicare & Medicaid Services (CMS) Administrator, Jay Bhattacharya, M.D., Ph.D., as Director of the National Institutes of Health (NIH), Dave Weldon, M.D., as Director of the…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
